RARE peer analysis
Ultragenyx Pharmaceutical (RARE) against its competitors: price, today's move, 1-year return and market value side by side.
- RARE's peers: ABEO (Abeona Therapeutics), BBIO (BridgeBio Pharma), BMRN (BioMarin Pharmaceuticals), FDMT (4D Molecular), MGTX (MeiraGTx), MREO (Mereo BioPharma), PTCT (PTC Therapeutics), QURE (uniQure).
RARE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABEO Abeona Therapeutics | $2.42 | -1.43% | -42.50% | $138.01M |
| BBIO BridgeBio Pharma | $76.03 | -2.75% | 16.01% | $14.81B |
| BMRN BioMarin Pharmaceuticals | $60.02 | -2.28% | 14.19% | $11.63B |
| FDMT 4D Molecular | $10.23 | -4.57% | -5.28% | $740.49M |
| MGTX MeiraGTx | $7.98 | -1.97% | 5.28% | $779.89M |
| MREO Mereo BioPharma | $0.28 | -4.94% | -84.81% | $219.59M |
| PTCT PTC Therapeutics | $56.99 | -2.29% | -24.62% | $4.76B |
| QURE uniQure | $20.12 | -0.54% | -28.01% | $1.41B |
| RCKT Rocket Pharmaceuticals | $2.01 | -4.77% | -30.23% | $224.36M |
| RGNX REGENXBIO | $7.12 | -0.84% | -34.86% | $470.79M |
| RARE Ultragenyx Pharmaceutical | $16.50 | -4.18% | -48.21% | $1.68B |